http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CO-2018013559-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00cf135003c69ae281b696d3bc73e0c9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
filingDate 2018-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57451cc394eceb5c6be8f9735aa582fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_767d6feb27229402dcca08e0d26ceffa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e79d4b45d89672b9361c2bc2ee597e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b80f62a775b576621301d31a2868db2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_399d59c1e97defe23fcb2f468a380aee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b63a96ed0a42bbde95cae5061900c3e
publicationDate 2019-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CO-2018013559-A2
titleOfInvention Specific trifluoroethyl quinoline analog for use in the treatment of activated phosphoinositide 3-kinase delta syndrome (apds)
abstract N - {(R) -1- [8-Chloro-2- (1-oxypyridin-3-yl) -quinolin-3-yl] -2,2,2-trifluoroethyl} -pyrido [3,2-d] Pyrimidin-4-ylamine is effective in the treatment and / or prevention of activated phosphoinositide 3-kinase delta syndrome (APDS).
priorityDate 2016-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414809476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574059
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12734305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68958

Total number of triples: 23.